Literature DB >> 24702943

Multiclonal spread of VIM-1-producing Enterobacter cloacae isolates associated with In624 and In488 integrons located in an IncHI2 plasmid.

Jennifer Villa1, Esther Viedma1, Patricia Brañas1, M Angeles Orellana1, Joaquín R Otero1, Fernando Chaves2.   

Abstract

Over a 6-year period (2007-2012), the emergence of Enterobacter cloacae isolates resistant to β-lactams and with reduced susceptibility to carbapenems was observed in Hospital Universitario 12 de Octubre (Madrid, Spain). To determine the possible role of metallo-β-lactamases (MBLs) in the resistance profile of these isolates, a molecular and clinical epidemiological study was performed, including determination of patients' clinical characteristics, genetic diversity of strains, resistance mechanisms to carbapenems, and the genetic environment of VIM-1. A total of 73 E. cloacae isolates showed resistance to extended-spectrum cephalosporins and reduced susceptibility to at least one carbapenem during 2007-2012. PCR amplification revealed the presence of bla(VIM-1) gene in 37 isolates, bla(VIM-2) in 1 isolate and bla(KPC) in 5 isolates. Molecular typing showed high clonal diversity of E. cloacae isolates carrying bla(VIM-1). The genetic environment of bla(VIM-1) was investigated and two integron structures were found: intI-bla(VIM-1)-aacA4-dfrB1-aadA1-catB2-qacEΔ1/sul1 (In624); and intI-bla(VIM-1)-aacA4-aadA1-qacEΔ1/sul1 (In488). Isolates belonging to three clones (A, F and G) harboured different types of integron (In624 or In488) despite belonging to the same clone. Conjugal experiments showed an association with a conjugative plasmid of ca. 300 kb belonging to IncHI2 group, which is common in Spanish hospitals, suggesting that the widespread dissemination of bla(VIM-1) may be due to horizontal transfer of mobile genetic determinants rather than the result of spreading of a few clones. These results have implications for infection control programmes in the hospital.
Copyright © 2014 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Keywords:  Enterobacter cloacae; IncHI2 plasmid; Integron; VIM-1

Mesh:

Substances:

Year:  2014        PMID: 24702943     DOI: 10.1016/j.ijantimicag.2014.02.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  13 in total

1.  Characterization of Carbapenemase-Producing Klebsiella oxytoca in Spain, 2016-2017.

Authors:  María Pérez-Vazquez; Jesús Oteo-Iglesias; Pedro J Sola-Campoy; Hugo Carrizo-Manzoni; Verónica Bautista; Noelia Lara; Belén Aracil; Almudena Alhambra; Luis Martínez-Martínez; José Campos
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3.

Authors:  Javier E Cañada-García; Zaira Moure; Pedro J Sola-Campoy; Mercedes Delgado-Valverde; María E Cano; Desirèe Gijón; Mónica González; Irene Gracia-Ahufinger; Nieves Larrosa; Xavier Mulet; Cristina Pitart; Alba Rivera; Germán Bou; Jorge Calvo; Rafael Cantón; Juan José González-López; Luis Martínez-Martínez; Ferran Navarro; Antonio Oliver; Zaira R Palacios-Baena; Álvaro Pascual; Guillermo Ruiz-Carrascoso; Jordi Vila; Belén Aracil; María Pérez-Vázquez; Jesús Oteo-Iglesias
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

3.  The first report of Enterobacter gergoviae carrying bla NDM-1 in Iran.

Authors:  Reza Khashei; Fatemeh Edalati Sarvestani; Yalda Malekzadegan; Mohammad Motamedifar
Journal:  Iran J Basic Med Sci       Date:  2020-09       Impact factor: 2.699

4.  Phenotypic and molecular detection of the bla KPC gene in clinical isolates from inpatients at hospitals in São Luis, MA, Brazil.

Authors:  Patricia Cristina Saldanha Ribeiro; Andrea Souza Monteiro; Sirlei Garcia Marques; Sílvio Gomes Monteiro; Valério Monteiro-Neto; Martina Márcia Melo Coqueiro; Ana Cláudia Garcia Marques; Rosimary de Jesus Gomes Turri; Simone Gonçalves Santos; Maria Rosa Quaresma Bomfim
Journal:  BMC Infect Dis       Date:  2016-12-07       Impact factor: 3.090

5.  Molecular Characteristics of Carbapenem-Resistant Enterobacter cloacae in Ningxia Province, China.

Authors:  Zhiyun Shi; Huizheng Zhao; Gang Li; Wei Jia
Journal:  Front Microbiol       Date:  2017-01-31       Impact factor: 5.640

6.  MALDI-TOF MS Identification and Clustering Applied to Enterobacter Species in Nosocomial Setting.

Authors:  Lucia De Florio; Elisabetta Riva; Annalisa Giona; Etleva Dedej; Marta Fogolari; Eleonora Cella; Silvia Spoto; Alessia Lai; Gianguglielmo Zehender; Massimo Ciccozzi; Silvia Angeletti
Journal:  Front Microbiol       Date:  2018-08-14       Impact factor: 5.640

7.  New Delhi Metallo-β-Lactamase 1(NDM-1), the Dominant Carbapenemase Detected in Carbapenem-Resistant Enterobacter cloacae from Henan Province, China.

Authors:  Cailin Liu; Shangshang Qin; Hui Xu; Lijuan Xu; Di Zhao; Xuchun Liu; Shaolei Lang; Xianju Feng; Hong-Min Liu
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

8.  Co-spread of metal and antibiotic resistance within ST3-IncHI2 plasmids from E. coli isolates of food-producing animals.

Authors:  Liangxing Fang; Xingping Li; Liang Li; Shumin Li; Xiaoping Liao; Jian Sun; Yahong Liu
Journal:  Sci Rep       Date:  2016-05-04       Impact factor: 4.379

9.  Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.

Authors:  Kalyan D Chavda; Liang Chen; Derrick E Fouts; Granger Sutton; Lauren Brinkac; Stephen G Jenkins; Robert A Bonomo; Mark D Adams; Barry N Kreiswirth
Journal:  MBio       Date:  2016-12-13       Impact factor: 7.867

10.  Antimicrobial susceptibility and molecular epidemiology of clinical Enterobacter cloacae bloodstream isolates in Shanghai, China.

Authors:  Su Wang; Shu-Zhen Xiao; Fei-Fei Gu; Jin Tang; Xiao-Kui Guo; Yu-Xing Ni; Jie-Ming Qu; Li-Zhong Han
Journal:  PLoS One       Date:  2017-12-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.